Introduction: The course of anosmia and ageusia in COVID-19 patients is not yet clearly known. We present short-term follow-up data concerning mild to moderate disease in home-quarantined COVID-19 patients in Greece. Methods: We provided a symptom questionnaire and instructions for a self-administered home smell-and-taste test to 79 positive COVID-19 patients from 2 tertiary hospitals in Greece. The patients recorded their subjective symptoms before and during infection as well as 4 weeks after the diagnosis. The patients also underwent the home test during infection and 4 weeks later. Results: Twenty-nine patients (36.7%) reported a loss of smell, and 21 (27.8%) reported a loss of taste, with equal prevalences between genders. We observed 2 types of recovery, i.e., a rapid, almost complete recovery, and a second slower and partial recovery. The type of recovery was not age related. A rapid recovery was observed in two thirds of the patients, with their olfactory ratings presenting a trend towards significance in correlation with nasal obstruction. A slow recovery in olfaction was correlated with low intensity ratings in odors with a trigeminal compound. The loss of taste was more pronounced in sweet and salty intensity ratings. Conclusion: Chemosensory deficits associated with COVID-19 infection were quite frequent among the Greek patients with mild or moderate disease who, in most cases, returned to normal within 4 weeks. However, 1 in 3 patients presented with persistent olfactory and gustatory dysfunction in the short term.

1.
Lechien
JR
,
Chiesa-Estomba
CM
,
De Siati
DR
,
Horoi
M
,
Le Bon
SD
,
Rodriguez
A
, et al.
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
.
Eur Arch Otorhinolaryngol
.
2020
Aug
;
277
(
8
):
2251
61
.
[PubMed]
0937-4477
2.
Beltrán-Corbellini
Á
,
Chico-García
JL
,
Martínez-Poles
J
,
Rodríguez-Jorge
F
,
Natera-Villalba
E
,
Gómez-Corral
J
, et al.
Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study
.
Eur J Neurol
.
2020
Apr
;
22
(
9
):
1738
41
. ;
Epub ahead of print
.
[PubMed]
1351-5101
3.
Vaira
LA
,
Salzano
G
,
Deiana
G
,
De Riu
G
.
Anosmia and Ageusia: Common Findings in COVID-19 Patients
.
Laryngoscope
.
2020
Jul
;
130
(
7
):
1787
.
[PubMed]
0023-852X
4.
Oleszkiewicz
A
,
Schriever
VA
,
Croy
I
,
Hähner
A
,
Hummel
T
.
Updated Sniffin’ Sticks normative data based on an extended sample of 9139 subjects
.
Eur Arch Otorhinolaryngol
.
2019
Mar
;
276
(
3
):
719
28
.
[PubMed]
0937-4477
5.
Landis
BN
,
Welge-Luessen
A
,
Brämerson
A
,
Bende
M
,
Mueller
CA
,
Nordin
S
, et al.
“Taste Strips” - a rapid, lateralized, gustatory bedside identification test based on impregnated filter papers
.
J Neurol
.
2009
Feb
;
256
(
2
):
242
8
.
[PubMed]
0340-5354
6.
Hummel
T
,
Whitcroft
KL
,
Andrews
P
,
Altundag
A
,
Cinghi
C
,
Costanzo
RM
, et al.
Position paper on olfactory dysfunction
.
Rhinol Suppl
.
2017
Mar
;
54
(
26
):
1
30
.
[PubMed]
1013-0047
7.
Stamps
JJ
,
Bartoshuk
LM
,
Heilman
KM
.
A brief olfactory test for Alzheimer’s disease
.
J Neurol Sci
.
2013
Oct
;
333
(
1-2
):
19
24
.
[PubMed]
0022-510X
8.
Vaira
LA
,
Salzano
G
,
Petrocelli
M
,
Deiana
G
,
Salzano
FA
,
De Riu
G
.
Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine
.
Head Neck
.
2020
Jul
;
42
(
7
):
1570
6
.
[PubMed]
1043-3074
9.
Kern
DW
,
Schumm
LP
,
Wroblewski
KE
,
Pinto
JM
,
Hummel
T
,
McClintock
MK
.
Olfactory thresholds of the U.S. Population of home-dwelling older adults: development and validation of a short, reliable measure
.
PLoS One
.
2015
Mar
;
10
(
3
):
e0118589
.
[PubMed]
1932-6203
10.
Iravani
B
,
Arshamian
A
,
Ravia
A
,
Mishor
E
,
Snitz
K
,
Shushan
S
, et al.
Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population
.
Chem Senses
.
2020
May
;
45
(
6
):
bjaa034
. ;
Epub ahead of print
.
[PubMed]
0379-864X
11.
Pingel
J
,
Ostwald
J
,
Pau
HW
,
Hummel
T
,
Just
T
.
Normative data for a solution-based taste test
.
Eur Arch Otorhinolaryngol
.
2010
Dec
;
267
(
12
):
1911
7
.
[PubMed]
0937-4477
12.
Hoffmann
M
,
Kleine-Weber
H
,
Schroeder
S
,
Krüger
N
,
Herrler
T
,
Erichsen
S
, et al.
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
.
Cell
.
2020
Apr
;
181
(
2
):
271
280.e8
.
[PubMed]
0092-8674
13.
Brann
D
,
Tsukahara
T
,
Weinreb
C
,
Logan
D
,
Datta
S
.
Non-neural expression of SARS CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients.
BioRxIv
.
2020
. doi:
14.
Li
YC
,
Bai
WZ
,
Hashikawa
T
.
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
.
J Med Virol
.
2020
Jun
;
92
(
6
):
552
5
.
[PubMed]
0146-6615
15.
Mao
L
,
Jin
H
,
Wang
M
,
Hu
Y
,
Chen
S
,
He
Q
, et al.
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
.
JAMA Neurol
.
2020
Jun
;
77
(
6
):
683
90
.
[PubMed]
2168-6149
16.
Parma
V
,
Ohla
K
,
Veldhuizen
MG
,
Niv
MY
,
Kelly
CE
,
Bakke
AJ
, et al.;
GCCR Group Author
.
More than smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis
.
Chem Senses
.
2020
Jun
;
•••
:
bjaa041
. ;
Epub ahead of print
.
[PubMed]
0379-864X
17.
Ren
Y
,
Yang
L
,
Guo
Y
,
Xutao
M
,
Li
K
,
Wei
Y
.
Intranasal trigeminal chemosensitivity in patients with postviral and post-traumatic olfactory dysfunction
.
Acta Otolaryngol
.
2012
Sep
;
132
(
9
):
974
80
.
[PubMed]
0001-6489
18.
Pellegrino
R
,
Walliczek-Dworschak
U
,
Winter
G
,
Hull
D
,
Hummel
T
.
Investigation of chemosensitivity during and after an acute cold
.
Int Forum Allergy Rhinol
.
2017
Feb
;
7
(
2
):
185
91
.
[PubMed]
2042-6976
19.
Sungnak
W
,
Huang
N
,
Bécavin
C
,
Berg
M
,
Queen
R
,
Litvinukova
M
, et al.;
HCA Lung Biological Network
.
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
.
Nat Med
.
2020
May
;
26
(
5
):
681
7
.
[PubMed]
1078-8956
20.
Varga
Z
,
Flammer
AJ
,
Steiger
P
,
Haberecker
M
,
Andermatt
R
,
Zinkernagel
AS
, et al.
Endothelial cell infection and endotheliitis in COVID-19
.
Lancet
.
2020
May
;
395
(
10234
):
1417
8
.
[PubMed]
0140-6736
21.
Hummel
T
,
Oehme
L
,
van den Hoff
J
,
Gerber
J
,
Heinke
M
,
Boyle
JA
, et al.
PET-based investigation of cerebral activation following intranasal trigeminal stimulation
.
Hum Brain Mapp
.
2009
Apr
;
30
(
4
):
1100
4
.
[PubMed]
1065-9471
22.
Wang
H
,
Zhou
M
,
Brand
J
,
Huang
L
.
Inflammation and taste disorders: mechanisms in taste buds
.
Ann N Y Acad Sci
.
2009
Jul
;
1170
(
1
):
596
603
.
[PubMed]
0077-8923
23.
Stone
LM
,
Wilcox
CL
,
Kinnamon
SC
.
Virus-mediated transfer of foreign DNA into taste receptor cells
.
Chem Senses
.
2002
Nov
;
27
(
9
):
779
87
.
[PubMed]
0379-864X
24.
Montalvan
V
,
Lee
J
,
Bueso
T
,
De Toledo
J
,
Rivas
K
.
Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
.
Clin Neurol Neurosurg
.
2020
Jul
;
194
:
105921
.
[PubMed]
0303-8467
25.
Sedaghat
AR
,
Gengler
I
,
Speth
MM
.
Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance
.
Otolaryngol Head Neck Surg
.
2020
Jul
;
163
(
1
):
12
5
.
[PubMed]
0194-5998
26.
Moein
ST
,
Hashemian
SM
,
Mansourafshar
B
,
Khorram-Tousi
A
,
Tabarsi
P
,
Doty
RL
.
Smell dysfunction: a biomarker for COVID-19
.
Int Forum Allergy Rhinol
.
2020
Aug
;
10
(
8
):
944
50
.
[PubMed]
2042-6976
27.
Tsivgoulis
G
,
Fragkou
PC
,
Delides
A
,
Karofylakis
E
,
Dimopoulou
D
,
Sfikakis
PP
, et al.
Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19)
.
J Neurol
.
2020
Aug
;
267
(
8
):
2193
5
.
[PubMed]
0340-5354
28.
Landis
BN
,
Hummel
T
,
Hugentobler
M
,
Giger
R
,
Lacroix
JS
.
Ratings of overall olfactory function
.
Chem Senses
.
2003
Oct
;
28
(
8
):
691
4
.
[PubMed]
0379-864X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.